Did the U.S pharmaceutical company Eli Lilly use a billion-dollar investment in Rhineland-Palatinate to pressure the German government to change the law?

Internal documents from the Ministry of Health confirm the suspicion that the pharmaceutical giant may have linked its settlement in Rhineland-Palatinate to a change in the law.

Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
Related Posts